Lietuvos sveikatos mokslų universitetas About Medicina Editorial Office Instructions to Authors Links Online Submission Old site

Medicina issued since 1920

Volume 50, Issue 1, 2014

Browse by category:

  • Abstracts
  • Articles
  • Clinical case reports
  • Guidelines
  • Reviews
  • Previous Issues

Never miss an issue!

Subscribe
Articles

Medicina (Kaunas) 2014; 50 (1): 19-27
DOI: 10.1016/j.medici.2014.05.004

Role of genetic factors on the effect of additional loading doses and two maintenance doses used to overcome clopidogrel hyporesponsiveness.

Gustavs Latkovskis 1,2,3
Inga Urtane 4
Agnese Knipse 5
Raitis Peculis 6
Inese Cakstina 7
Janis Klovins 6
Andrejs Erglis 1,2,3
1 Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital, Riga, Latvia
2 Research Institute of Cardiology, University of Latvia, Riga, Latvia
3 Faculty of Medicine, University of Latvia, Riga, Latvia
4 Faculty of Pharmacy, Riga Stradins University, Riga, Latvia
5 Latvian Centre of Cardiology, Paul Stradins Clinical University Hospital, Riga, Latvia
6 Latvian Biomedical Research and Study Centre, Riga, Latvia
7 Cell Transplantation Centre, Paul Stradins Clinical University Hospital, Riga, Latvia
Keywords
ABCB1
Clopidogrel resistance
CYP2C19
CYP2C9
VASP

Additional loading doses and higher maintenance doses (MDs) have been used to overcome hyporesponsiveness of clopidogrel. We aimed to investigate whether genetic polymorphisms of two cytochromes (CYP2C19 and CYP2C9) and ABCB1 modify effect of such dose-adjustment strategy.
We enrolled 118 patients undergoing elective or acute percutaneous coronary intervention (PCI) with drug eluting stent (DES). Platelet reactivity index (PRI) was measured using the vasodilator-stimulated phosphoprotein (VASP) index and a cut-off value of ≥60% was defined as hyporesponsiveness. Polymorphism of two cytochromes (CYP2C19, CYP2C9) and gene ABCB1 were determined. In patients hyporesponsive to the initial LD the dose-adjustment was performed using up to 3 additional 600mg LDs in order to achieve PRI <60%, and both 150mg and 75mg MD were tested at the follow-up. Patients with at least one CYP2C19*2 allele had higher baseline PRI after the initial LD (78.2±13.1 vs. 65.3±19.5, P=0.005). The PRI reduction with additional LD was significantly smaller in carriers of the CYP2C19*2 (25.2±15.6 vs. 35.5±16.8, P=0.025) and similar trend was observed with subsequent additional LDs. Both MDs were less effective in presence of CYP2C19*2. Target PRI was, however, more frequently achieved with higher MD even in presence of CYP2C19*2 (in 70.6% vs. 23.5% of hyporesponders, P=0.008). No such differences were observed for other polymorphisms. In patients hyporesponsive to a routine clopidogrel doses the potency of additional LD and higher MD of clopidogrel is compromised by presence of CYP2C19*2 allele. The dose-adjustment strategy is not affected by ABCB1 C3435T or CYP2C9 genotypes.

Correspondence to A. Erglis Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital, Pilsonu 13, 1002 Riga, Latvia. E-mail address: a.a.erglis@stradini.lv

Received 18 September 2013, accepted 28 February 2014, available online 6 June 2014.

Also in this category

Abstracts of the International Scientific Conference on Medicine organized within the frame of the 82nd International Scientific Conference of the University of Latvia Riga, Latvia

Abstracts accepted for the Scientific and Practical Conference “MODERN MEDICINE: a NEW APPROACH and RELEVANT RESEARCH” among the medical educational organizations of Kazakhstan, FSU and beyond, confined to the World Osteoporosis Day (WOD) conducted within the framework of NTP AR09563004 “Features of metabolism and the state of bone mineral density in adolescent girls with primary dysmenorrhea”

Also from this Author

Articles

Management of coronary artery disease patients in Latvia compared with practice in Central-Eastern Europe and globally: Analysis of the CLARIFY registry.

(pages: 240-6)
Andrejs Erglis
Iveta Mintāle
Gustavs Latkovskis
et al.
Download

Articles

Insufficient control of heart rate in stable coronary artery disease patients in Latvia.

(pages: 295-302)
Inga Balode
Iveta Mintāle
Gustavs Latkovskis
et al.
Download

Medicina is a peer-reviewed monthly scientific journal of Lithuanian Medical Association, Lithuanian University of Health Sciences and Vilnius University

eISSN 1648-9144

ISSN 1010-660X

2021 © Lithuanian University of Health Sciences, A. Mickevičiaus g. 9, LT 44307 Kaunas.

Tel. +370 37 327229, Faks. +370 37 220733, E-mail: medicina.editor (at) lsmuni.lt

Concept & code – BÜRO